Pastāsti draugiem par šo preci:
Innovation versus Financialization in the US Pharmaceutical Industry - Elements in Corporate Governance Tulum, Oner (The Academic-Industry Research Network)
Cena
€ 90,49
Pasūtīts no attālās noliktavas
Paredzamā piegāde . gada 19. - 27. nov.
Ziemassvētku dāvanas var atgriezt līdz 31. janvārim
Saņemiet paziņojumus par jauniem Tulum, Oner (The Academic-Industry Research Network) izdevumiem
Mūsu klienti saka:
Pievienot savam iMusic vēlmju sarakstam
Pieejams arī kā:
Innovation versus Financialization in the US Pharmaceutical Industry - Elements in Corporate Governance
Tulum, Oner (The Academic-Industry Research Network)
The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.'
| Mediji | Grāmatas Hardcover Book (Grāmata ar cieto muguriņu un vāku) |
| Izlaists | 2025. gada 20. novembris |
| ISBN13 | 9781009707992 |
| Izdevēji | Cambridge University Press |
| Lapas | 96 |
| Izmēri | 152 × 229 × 6 mm · 239 g (Svars (aptuveni)) |
| Valoda | Angļu |
